With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- 5 ways parents can support their children to save up for Christmas Sep 27, 2021
- Men and women: former tronista is with Matteo Salvini Sep 8, 2021
- Death of Ashley Ross, star of reality tv affect of dwarfism : it is the origin of the car accident May 6, 2020
- “Spread your wings and get ready to fly”: Yolanda Andrade’s heartfelt farewell after the surprise death of her half brother Oct 29, 2020
- Genocide of the Tutsis: “The silence of the words”, the doc in 2 minutes of Saturday Nov 19, 2022
- Rai appointments: the postponement requested by the M5S suits everyone, especially Mario Draghi Jul 7, 2021
- Meghan Markle influenceuse : the duchess would think about it to boost his blog May 5, 2020